phenylethanolamine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2025 (NCT07116421)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
PNMT substrate
Chemistry & pharmacology
Loading structure…
SMILES
NCC(O)c1ccc(Cl)c(Cl)c1- Mol. weight
- 206.07 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL224526 ↗
Also known as
- apophedrin
- bisnorephedrin
- bisnorephedrin
- bisnorephedrin
- norphedrin
- phenethanolamine
- phenylethanolamine
- phenylethanolamine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07116421 | Early Phase 1 (Phase 1) | Jul 1, 2025 | Vanderbilt University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vanderbilt University | Academic/Hospital | 1 | 1 | 1 | 2025 |
1 organizations
Page 1 / 1